Celsius Holdings, Inc. (NASDAQ:CELH – Free Report) – Investment analysts at William Blair dropped their Q2 2024 EPS estimates for shares of Celsius in a report released on Tuesday, May 7th. William Blair analyst J. Andersen now forecasts that the company will post earnings per share of $0.25 for the quarter, down from their previous estimate of $0.26. The consensus estimate for Celsius’ current full-year earnings is $1.09 per share. William Blair also issued estimates for Celsius’ Q3 2024 earnings at $0.30 EPS, Q4 2024 earnings at $0.30 EPS, FY2024 earnings at $1.06 EPS and FY2025 earnings at $1.45 EPS.
Celsius (NASDAQ:CELH – Get Free Report) last announced its quarterly earnings data on Tuesday, May 7th. The company reported $0.27 EPS for the quarter, topping analysts’ consensus estimates of $0.20 by $0.07. Celsius had a return on equity of 131.58% and a net margin of 17.21%. The firm had revenue of $355.70 million during the quarter, compared to analyst estimates of $390.37 million. During the same period last year, the company earned $0.13 earnings per share. The company’s revenue was up 36.9% on a year-over-year basis.
Read Our Latest Research Report on CELH
Celsius Stock Performance
CELH opened at $82.07 on Thursday. The company has a fifty day moving average price of $81.43 and a two-hundred day moving average price of $66.08. The firm has a market capitalization of $18.96 billion, a PE ratio of 106.58, a P/E/G ratio of 2.22 and a beta of 1.93. Celsius has a 52 week low of $39.50 and a 52 week high of $99.62.
Insider Activity
In related news, Director Caroline S. Levy sold 20,000 shares of the stock in a transaction dated Wednesday, March 13th. The stock was sold at an average price of $94.77, for a total transaction of $1,895,400.00. Following the completion of the transaction, the director now directly owns 37,891 shares in the company, valued at $3,590,930.07. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In other Celsius news, insider Paul H. Storey sold 1,833 shares of the business’s stock in a transaction dated Tuesday, May 7th. The shares were sold at an average price of $75.43, for a total transaction of $138,263.19. Following the sale, the insider now directly owns 41,044 shares of the company’s stock, valued at approximately $3,095,948.92. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Caroline S. Levy sold 20,000 shares of the firm’s stock in a transaction dated Wednesday, March 13th. The shares were sold at an average price of $94.77, for a total value of $1,895,400.00. Following the completion of the transaction, the director now owns 37,891 shares of the company’s stock, valued at approximately $3,590,930.07. The disclosure for this sale can be found here. Insiders have sold a total of 2,045,196 shares of company stock worth $131,499,404 over the last three months. Corporate insiders own 2.20% of the company’s stock.
Institutional Inflows and Outflows
Several large investors have recently bought and sold shares of the stock. Cary Street Partners Investment Advisory LLC boosted its holdings in shares of Celsius by 1,350.0% in the 3rd quarter. Cary Street Partners Investment Advisory LLC now owns 145 shares of the company’s stock valued at $25,000 after buying an additional 135 shares during the last quarter. Contravisory Investment Management Inc. acquired a new stake in Celsius in the fourth quarter valued at $25,000. Transcendent Capital Group LLC bought a new position in shares of Celsius in the 4th quarter valued at about $25,000. FinTrust Capital Advisors LLC acquired a new position in shares of Celsius during the 1st quarter worth about $25,000. Finally, Tidemark LLC bought a new stake in shares of Celsius in the 4th quarter valued at about $29,000. 60.95% of the stock is owned by institutional investors and hedge funds.
Celsius Company Profile
Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.
See Also
- Five stocks we like better than Celsius
- 3 Fintech Stocks With Good 2021 Prospects
- Roblox: The Bottom Just Fell Out of the Metaverse
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Airbnb Stock Plummets After Earnings, But is It a Buy?
- How Technical Indicators Can Help You Find Oversold StocksĀ
- Uber’s Earnings Drop Is Investors Opportunity
Receive News & Ratings for Celsius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celsius and related companies with MarketBeat.com's FREE daily email newsletter.